Thomas Lindsay
Direktor/Vorstandsmitglied bei GENEDRIVE PLC
Vermögen: 16 859 $ am 30.04.2024
Aktive Positionen von Thomas Lindsay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENEDRIVE PLC | Direktor/Vorstandsmitglied | 09.04.2018 | - |
TRINITY BIOTECH PLC | Direktor/Vorstandsmitglied | 26.10.2022 | - |
Independent Dir/Board Member | 26.10.2022 | - | |
Vertrieb & Marketing | - | - |
Karriereverlauf von Thomas Lindsay
Ehemalige bekannte Positionen von Thomas Lindsay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Abbott Rapid Diagnostics ULC
Abbott Rapid Diagnostics ULC Medical DistributorsDistribution Services Part of Abbott Laboratories, Abbott Rapid Diagnostics ULC is a world leader in rapid point of care (POC) solutions. The company's focus is on creating patient-centered diagnostic tests that can provide invaluable answers to doctors, healthcare professionals, and nurses when and where they are needed most. The company is based in Ottawa, Canada. The Canadian company provides innovative diagnostic tests for critical areas such as cardiology, infectious disease, and toxicology. | Corporate Officer/Principal | - | 01.01.2017 |
NIGERIAN-GERMAN CHEMICALS PLC | Direktor/Vorstandsmitglied | 22.07.2011 | - |
Ausbildung von Thomas Lindsay
Glasgow Caledonian University | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 3 |
Nigeria | 2 |
Kanada | 2 |
Operativ
Director/Board Member | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
NIGERIAN-GERMAN CHEMICALS PLC | Health Technology |
GENEDRIVE PLC | Health Technology |
TRINITY BIOTECH PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
Abbott Rapid Diagnostics ULC
Abbott Rapid Diagnostics ULC Medical DistributorsDistribution Services Part of Abbott Laboratories, Abbott Rapid Diagnostics ULC is a world leader in rapid point of care (POC) solutions. The company's focus is on creating patient-centered diagnostic tests that can provide invaluable answers to doctors, healthcare professionals, and nurses when and where they are needed most. The company is based in Ottawa, Canada. The Canadian company provides innovative diagnostic tests for critical areas such as cardiology, infectious disease, and toxicology. | Distribution Services |
- Börse
- Insiders
- Thomas Lindsay
- Erfahrung